We tested the hypothesis that decreases in dopamine, measured by nigral tyrosine hydroxylase (TH) expression and striatal dopamine content, may result in compensatory increased postsynaptic striatal dopamine D2/3 receptor binding and neuroinflammation, even at early stages of PD-like neurodegeneration. Here, TH is linked to Parkinson disease.